Nicholas P. Restifo
Impact in
- Immunology top 0.01%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
- Oncology top 0.01%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 287
- Immunotherapy and Immune Responses 221
- Immune Cell Function and Interaction 131
- T-cell and B-cell Immunology 110
- Oncology 178
- CAR-T cell therapy research 147
- Cancer Immunotherapy and Biomarkers 43
- Co-authors
- Steven A. Rosenberg (134 shared papers)Luca Gattinoni (64 shared papers)Mark E. Dudley (20 shared papers)James C. Yang (24 shared papers)Zhiya Yu (71 shared papers)Christopher A. Klebanoff (40 shared papers)Douglas C. Palmer (60 shared papers)Richard M. Sherry (27 shared papers)
- Journals
- The Journal of Immunology (42 papers)Journal of Immunotherapy (22 papers)The Journal of Experimental Medicine (18 papers)Journal of Clinical Investigation (18 papers)Blood (16 papers)
- Partner nations
- United StatesAustraliaMalaysia
In The Last Decade
Nicholas P. Restifo
344 papers receiving 64.5k citations
Nicholas P. Restifo's Hit Papers
Peers
Comparison fields: 5 of 167
- Immunology 42.7k
- Oncology 36.7k
- Genetics 9.0k
- Biotechnology 2.5k
- Molecular Biology 16.6k
Countries citing papers authored by Nicholas P. Restifo
This map shows the geographic impact of Nicholas P. Restifo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas P. Restifo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas P. Restifo more than expected).
Fields of papers citing papers by Nicholas P. Restifo
This network shows the impact of papers produced by Nicholas P. Restifo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas P. Restifo. The network helps show where Nicholas P. Restifo may publish in the future.
Co-authors
The 25 scholars most cited alongside Nicholas P. Restifo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 347 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cancer immunotherapy: moving beyond current vaccines Hit paper breakdown → | 2004 | 2293 |
| 2 | Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes Hit paper breakdown → | 2002 | 2175 |
| 3 | Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes Hit paper breakdown → | 2006 | 1977 |
| 4 | Adoptive cell transfer as personalized immunotherapy for human cancer Hit paper breakdown → | 2015 | 1850 |
| 5 | Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy Hit paper breakdown → | 2011 | 1618 |
| 6 | Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma Hit paper breakdown → | 1998 | 1478 |
| 7 | A human memory T cell subset with stem cell–like properties Hit paper breakdown → | 2011 | 1400 |
| 8 | Adoptive immunotherapy for cancer: harnessing the T cell response Hit paper breakdown → | 2012 | 1309 |
| 9 | Adoptive cell transfer: a clinical path to effective cancer immunotherapy Hit paper breakdown → | 2008 | 1264 |
| 10 | Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma Hit paper breakdown → | 2003 | 1235 |
| 11 | Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens Hit paper breakdown → | 2008 | 1022 |
| 12 | Defining ‘T cell exhaustion’ Hit paper breakdown → | 2019 | 1007 |
| 13 | Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8 + T cells Hit paper breakdown → | 2005 | 821 |
| 14 | Natural selection of tumor variants in the generation of “tumor escape” phenotypes Hit paper breakdown → | 2002 | 808 |
| 15 | T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis Hit paper breakdown → | 2010 | 798 |
| 16 | Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells Hit paper breakdown → | 2009 | 782 |
| 17 | Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4 Hit paper breakdown → | 2005 | 773 |
| 18 | Central memory self/tumor-reactive CD8 + T cells confer superior antitumor immunity compared with effector memory T cells Hit paper breakdown → | 2005 | 760 |
| 19 | Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8+ T Cells Hit paper breakdown → | 2003 | 751 |
| 20 | Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function Hit paper breakdown → | 2013 | 739 |
About Nicholas P. Restifo
Nicholas P. Restifo is a scholar working on Immunology, Oncology, Molecular Biology, Genetics and Biotechnology, having authored 347 papers that have together received 65.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (221 papers), CAR-T cell therapy research (147 papers), Immune Cell Function and Interaction (131 papers), T-cell and B-cell Immunology (110 papers), Virus-based gene therapy research (61 papers), Cancer Immunotherapy and Biomarkers (43 papers), vaccines and immunoinformatics approaches (37 papers) and RNA Interference and Gene Delivery (21 papers). The work is most often cited by research in Immunology (42.7k citations), Oncology (36.7k citations), Genetics (9.0k citations), Biotechnology (2.5k citations) and Molecular Biology (16.6k citations). Nicholas P. Restifo has collaborated with scholars based in United States, Australia and Malaysia. Frequent co-authors include Steven A. Rosenberg, Luca Gattinoni, Mark E. Dudley, James C. Yang, Zhiya Yu, Christopher A. Klebanoff, Douglas C. Palmer, Richard M. Sherry, Pawel Muranski and James Chih‐Hsin Yang. Their work appears in journals such as The Journal of Immunology, Journal of Immunotherapy, The Journal of Experimental Medicine, Journal of Clinical Investigation and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.